SAS-B deep dive: approvals climb 26% in 2025 as flower overtakes oil and pastilles surge by Adam Sheldon January 13, 2026January 14, 2026 The number of medicinal cannabis approvals through the Special Access Scheme climbed sharply in 2025, although […]
SAS-B approvals slow in August but pastille scripts continue to rise by Steve Jones September 3, 2025September 8, 2025
July SAS-B approvals edge higher as pastilles share rises beyond 20% by Adam Sheldon August 5, 2025August 6, 2025
SAS-B deep dive: approvals up 27% as flower officially overtakes oil by Adam Sheldon July 3, 2025July 3, 2025
SAS-B deep dive: approvals soar in ’24 with category five medicine leading the charge by Steve Jones January 22, 2025January 22, 2025
Pastilles continue steady SAS-B growth but flower retains top spot by Steve Jones December 4, 2024April 11, 2025
SAS-B deep dive: half-year data illustrates shifting sands as monthly approvals hit almost 20,000 by Steve Jones July 3, 2024July 3, 2024
